MedTrace Logo

Oculomotor Training in Spastic Diplegia: Effects on Postural Stability and Motor Proficiency

NCT07731074 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2026-07-28

No results posted yet for this study

Summary

This randomized clinical trial investigates the effect of oculomotor training on postural stability and motor proficiency in children with spastic diplegia. Participants will undergo structured oculomotor exercises designed to enhance visual-motor integration and balance control. Outcomes will be assessed using standardized measures of postural stability and motor proficiency before and after intervention. The study aims to determine whether targeted oculomotor training can improve functional motor performance and balance in this pediatric population.

By evaluating the effect of structured oculomotor training on postural stability and motor proficiency in children with spastic diplegia, the study seeks to establish whether visual-motor interventions can serve as effective adjuncts to conventional therapy. The rationale is grounded in neuroplasticity: repeated oculomotor exercises may strengthen neural pathways linking visual input to motor output, thereby improving balance and functional performance.

Conditions

  • Cerebral Palsy Spastic Diplegia

Interventions

BEHAVIORAL

Oculomotor Training

Exercises include saccadic eye movements, smooth pursuit, fixation, and visual scanning tasks.

BEHAVIORAL

Conventional Physiotherapy

physiotherapy focusing on stretching, strengthening, and balance training.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2026-10-15
Completion
2026-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07731074 on ClinicalTrials.gov